CRIS Current Research Information System

FARINA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.237
AS - Asia 9.808
EU - Europa 7.342
SA - Sud America 694
AF - Africa 508
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 24
Totale 29.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.110
SG - Singapore 2.905
CN - Cina 2.620
VN - Vietnam 2.164
GB - Regno Unito 1.829
IT - Italia 1.238
DE - Germania 948
SE - Svezia 813
HK - Hong Kong 667
UA - Ucraina 539
BR - Brasile 523
FR - Francia 489
IN - India 453
RU - Federazione Russa 402
IE - Irlanda 334
KR - Corea 209
JP - Giappone 196
ZA - Sudafrica 168
NL - Olanda 133
EE - Estonia 124
FI - Finlandia 111
TG - Togo 104
CI - Costa d'Avorio 95
CH - Svizzera 94
ID - Indonesia 77
TH - Thailandia 75
AR - Argentina 72
PH - Filippine 71
CA - Canada 56
SC - Seychelles 55
BG - Bulgaria 54
TR - Turchia 46
BD - Bangladesh 43
IQ - Iraq 43
MX - Messico 43
BE - Belgio 39
MY - Malesia 36
GR - Grecia 35
EC - Ecuador 33
AT - Austria 29
JO - Giordania 28
PL - Polonia 28
NG - Nigeria 24
SA - Arabia Saudita 24
EU - Europa 21
IR - Iran 21
ES - Italia 20
PK - Pakistan 20
CO - Colombia 19
AU - Australia 17
RO - Romania 16
VE - Venezuela 15
TW - Taiwan 14
UZ - Uzbekistan 14
LT - Lituania 13
MA - Marocco 13
LB - Libano 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
CL - Cile 9
CZ - Repubblica Ceca 9
DK - Danimarca 9
EG - Egitto 7
IL - Israele 7
NO - Norvegia 7
PS - Palestinian Territory 7
CR - Costa Rica 6
LK - Sri Lanka 6
NP - Nepal 6
PE - Perù 6
PT - Portogallo 6
AZ - Azerbaigian 5
HU - Ungheria 5
MU - Mauritius 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CY - Cipro 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
OM - Oman 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BO - Bolivia 3
CV - Capo Verde 3
DZ - Algeria 3
KH - Cambogia 3
MD - Moldavia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
ZM - Zambia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
GD - Grenada 2
Totale 29.608
Salva come PNG Salva come JPEG
Città #
Singapore 2.026
Southend 1.517
Fairfield 1.344
Ashburn 1.115
Chandler 682
Woodbridge 645
Hong Kong 637
Wilmington 571
Seattle 569
Ho Chi Minh City 550
Houston 529
Hefei 511
Hanoi 432
San Jose 418
Cambridge 415
Princeton 395
Jacksonville 385
Ann Arbor 358
Beijing 326
Santa Clara 311
Dublin 265
Boardman 250
Dong Ket 242
Bologna 232
Seoul 189
Lauterbourg 187
Tokyo 178
Nanjing 171
Westminster 161
Los Angeles 156
Padova 153
Menlo Park 144
Berlin 123
Turin 108
Lomé 104
Dallas 100
Helsinki 100
Milan 98
New York 96
Abidjan 93
Buffalo 93
San Diego 86
Shenyang 83
Jinan 79
Saint Petersburg 73
Da Nang 69
Guangzhou 68
Mülheim 68
Council Bluffs 65
Frankfurt am Main 64
Nanchang 61
Bern 59
Redondo Beach 59
São Paulo 59
Changsha 58
Sofia 53
Shanghai 52
Bengaluru 48
Bangkok 46
Dearborn 46
Haiphong 45
Jakarta 44
Des Moines 43
Hebei 42
Mahé 42
Florence 41
London 41
Tianjin 40
Phoenix 39
Verona 37
Brussels 36
Chicago 36
Rome 36
Zhengzhou 34
Olalla 33
Orem 30
Munich 29
Ningbo 27
Bremen 25
Jiaxing 25
Amman 24
Redwood City 24
Abeokuta 23
Johannesburg 23
Nuremberg 23
San Francisco 23
Falkenstein 22
Hangzhou 22
Redmond 22
Wuhan 22
Kuban 21
Manila 21
Medford 21
Baghdad 20
Taizhou 20
Amsterdam 19
Biên Hòa 19
Ninh Bình 19
Thái Nguyên 19
Brooklyn 18
Totale 19.325
Salva come PNG Salva come JPEG
Nome #
metodo e kit per la diagnosi prenatale di cardiopatie congenite 496
Highly active antiretroviral therapy in a resourse-limited setting: impact on the pregnancy outcome of HIV-infected women. 411
Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia 285
Fetal cardiac defects and third-trimester maternal serum placental growth factor 278
Accuracy of fetal gender determination in the first trimester using three-dimensional ultrasound. 278
Changes in Artery Diameters and Fetal Growth in Cases of Isolated Single Umbilical Artery 272
P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 262
Intrahepatic Cholestasis of Pregnancy: mRNAs for LIPF and ELOVL4 Genes Are Not Detectable in Circulating Maternal Plasma. 247
PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester. 238
Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. 233
Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome. 230
Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: A model to study the relevance of stress response in longevity 230
Prenatal diagnosis of a complete mole coexisting with a dichorionic twin pregnancy: case report. 229
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. 222
Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique 221
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. 221
Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. 220
Brainstem-vermis and brainstem-tentorium angles allow accurate categorization of fetal upward rotation of cerebellar vermis 213
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 213
Dynamic changes of fetal head descent at term before the onset of labor correlate with labor outcome and can be improved by ultrasound visual feedback 212
IN GRAVIDANZE A TERMINE SOTTOPOSTE A INDUZIONE I LIVELLI DELL’mRNA DEL PLAC1 NEL SANGUE MATERNO SONO CORRELATI CON L’INTERVALLO DI TEMPO CHE INTERCORRE TRA LA PRIMA SOMMINISTRAZIONE DI GEL A BASE DI DINOPROSTONE E IL PARTO 210
Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. 209
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 209
Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. 201
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients 200
The impact of assisted reproductive technology and chorionicity in twin pregnancies complicated by obstetric cholestasis 196
PLAC4 and beta-HCG mRNA levels are not altered in the maternal circulation of pregnancy with trisomy 21 191
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 191
Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction 188
Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. 183
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening. 183
Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study 183
Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. 182
Congenital heart defects: is it time to explore maternal blood for a non-invasive genetic screening test? 180
Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. 180
Velamentous cord insertion and atypical variable decelerations with no accelerations. 179
Multivariable evaluation of term birth weight: a comparison between ultrasound biometry and symphysis-fundal height 179
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 178
Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. 176
Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. 176
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. 176
Umbilical cord insertion into the lower segment of the uterus at 11 to 13 weeks' gestation is associated with maternal serum PAPP-A. 176
PLAC1 mRNA levels in maternal blood at induction of labor correlate negatively with induction-delivery interval. 175
Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. 174
Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10-11 weeks' gestation 174
Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis 172
Ultrasound screening for congenital pyelectasis in term pregnancies 171
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis 171
Automated Measurement of the Angle of Progression in Labor: A Feasibility and Reliability Study 171
Cord insertion into the lower third of the uterus in the first trimester is associated with placental and umbilical cord abnormalities 170
Analysis of the ultrasonographic findings predictive of vasa previa. 170
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. 169
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 167
Non-syndromic orofacial clefts in Southern Italy: pattern analysis according to gender, history of maternal smoking, folic acid intake and familial diabetes. J Craniomaxillofac Surg. 167
Delivery and immigration: the experience of an Italian hospital. 167
A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes 166
The Tei index for evaluation of fetal myocardial performance in sick fetuses 165
Antioxidant supplementation in pregnant women with low antioxidant status. 165
Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. 165
Lower maternal PLAC1 mRNA in pregnancies complicated with vaginal bleeding (threatened abortion <20 weeks) and a surviving fetus. 165
Biophysical markers for abnormal placentation: first and/or second trimester 165
Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities 164
Delaire's cheilorhinoplasty: Unilateral cleft aesthetic outcome scored according to the EUROCLEFT guidelines 163
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. 163
An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens 161
Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. 160
Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. 157
Predizione ecografica dell’infezione congenita sintomatica da cytomegalovirus 153
LA CRIOCONSERVAZIONE DEI GAMETI: IMPLICAZIONI ALLA LUCE DELLA LEGGE 40/2004 153
Prospective evaluation of the risk of pre-eclampsia using logistic regression analysis. 153
PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. 152
Bcl-2 as prognostic factor in head and neck squamous cell carcinoma. 151
Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. 150
Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature 150
Abnormal circulating maternal mirna expression is associated with a low (<4%) cell-free dna fetal fraction 150
Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery. 149
Effect of c-Met expression on survival in head and neck squamous cell carcinoma. 148
Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study 148
Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening 148
Levels of Circulating mRNA for the Tenascin-X (TNXB) Gene in Maternal Plasma at the Second Trimester in Pregnancies with Isolated Congenital Ventricular Septal Defects 148
A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID ‐19) pandemic 148
Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound. 147
Normal morphometry of fetal posterior fossa at midtrimester: brainstem-tentorium angle and brainstem-vermis angle. 147
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation 147
Three-dimensional ultrasound is an accurate and reproducible technique for fetal crown-rump length measureme 147
Prospective longitudinal cohort study of uterine arteries Doppler in singleton pregnancies obtained by IVF/ICSI with oocyte donation or natural conception 147
Impatto della HAART(Higly Active Antiretroviral Therapy) sull’outcome delle gravidanze di donne HIV positive in contesti a risorse limitate 146
Prenatal screening for developmental displacement of the hip: The buddha (pre-birth ultrasound for developmental displacement of the hip assessment) study 146
Clinical outcome of 285 Medpor grafts used for craniofacial reconstruction. 144
Infezione da HIV e gravidanza: profilassi versus terapia antiretrovirale altamente efficace 143
Prospective evaluation of ultrasound and biochemical‐based multivariable models for the prediction of late pre‐eclampsia 143
Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation. 142
Uterine artery Doppler and biochemical markers (PAPP-A, PlGF, sFlt-1, P-selectin, NGAL) at 11+0 to 13+6weeks in the prediction of late (>34weeks) pre-eclampsia 142
Caesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexate 142
Impact of HAART (Highly Active Antiretroviral Therapy) on the outcome of pregnancy in a resource-limited setting 142
Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. 140
TGF Alpha Has Low Protein Expression in Nonsyndromic Clefts. 138
Sonographic evaluation of the fetal spine position and success rate of manual rotation of the fetus in occiput posterior position: A randomized controlled trial 138
Correlation between umbilical arterial pH values and fetal vertebral artery Doppler waveforms at the beginning of the second stage of labor: a pilot prospective study 138
beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. 137
Totale 18.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 342
Totale 82.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021954 0 0 0 0 0 0 0 0 0 171 168 615
2021/20223.155 201 91 240 359 317 151 86 229 114 185 599 583
2022/20233.300 395 479 193 399 210 236 91 175 490 116 342 174
2023/2024892 94 157 81 94 78 130 45 64 24 49 29 47
2024/20253.615 155 553 318 264 512 249 219 98 73 197 139 838
2025/20269.463 923 1.221 1.014 786 1.190 674 1.127 301 1.588 639 0 0
Totale 30.177